BLADDER EA8185
Study #EA8185Phase 2 Study of Bladder-Sparing Chemoradiation with MEDI4736 (durvalumab) in Clinical Stage 3, node Positive Bladder Cancer (INSPIRE)
Back To Clinical Trials NCI Database Entry
Phase 2 Study of Bladder-Sparing Chemoradiation with MEDI4736 (durvalumab) in Clinical Stage 3, node Positive Bladder Cancer (INSPIRE)
Back To Clinical Trials NCI Database Entry